Výsledky vyhledávání - "Hana Gadassi"

Abstract B30: A phase 1 open label, dose-escalation trial evaluating the safety and tolerability of EF-022, macrophage activator, in subjects with advanced solid malignancies

Autor: Michal Shahar, Talia Golan, Uri Yogev, Aliza Ackerstein, Steve Raskin, Raanan Berger, Alexander M. Lesokhin, David Sidransky, Hana Gadassi, Mark L. Levitt

Publikováno v: Molecular Cancer Therapeutics. 14:B30-B30

Scientific background: Activated macrophages, present in excess during natural inflammatory responses, bear the potential to kill and eradicate cancer cells. Efranat has developed cancer immunotherapy based on macrophage activation using a plasma pro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6e903cd5c54793e5663d1aa93021c722
https://doi.org/10.1158/1535-7163.targ-15-b30

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání